Elise A Chong, MD

faculty photo
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
12th Floor, South Pavilion
Philadelphia, PA 19104
AB (Ecology and Evolutionary Biology )
University of Pennsylvania , 2007.
Non-degree (Graduate courses )
University of Pennsylvania, 2009.
MD (Medical Degree)
Perelman School of Medicine, University of Pennsylvania , 2013.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Jakub Svoboda, Steven M. Bair, Daniel J. Landsburg, Sunita Dwivedy Nasta, Sarah J.Nagle, Stefan K. Barta, Nadia Khan, Joanne Filicko-O'Hara, Sameh Gaballa, Lauren Strelec, Elise Chong, Sheryl Mitnick, Terease S. Waite, Cara King, Hatcher Ballard, Matthew Youngman, James Gerson, John P. Plastaras, Amit Maity, Agata M. Bogusz, Stacy S. Hung, Hisae Nakamura, Reza Nejati, Christian Steidl, Megan Lim, Marco Ruella and Stephen J.Schuster: Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas. Haematologica May 2020.

Elise A. Chong, Lindsey E. Roeker, Mazyar Shadman, Matthew S. Davids, Stephen J. Schuster and Anthony R. Mato: BTK inhibitors in cancer patients with COVID19: “The winner will be the one who controls that chaos” (Napoleon Bonaparte). American Association for Cancer Research April 2020.

Tania Jain, Merav Bar, Ankit J Kansagra, Elise A Chong, Shahrukh K Hashmi, Sattva S Neelapu, Michael Byrne, Elad Jacoby, Aleksandr Lazaryan, Caron A Jacobson, Stephen M Ansell, Farrukh T Awan, Linda Burns, Veronika Bachanova, Catherine M Bollard, Paul A Carpenter, John F DiPersio, Mehdi Hamadani, Helen E Heslop, Joshua A Hill, Krishna V Komanduri , Craig A Kovitz, Hillard M Lazarus, Justin M Serrette, Mohamad Mohty, David Miklos, Arnon Nagler, Steven Z Pavletic, Bipin N Savani, Stephen J Schuster, Mohamed A Kharfan-Dabaja, Miguel-Angel Perales, Yi Lin : Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion From the American Society for Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation 25(12): 2305-2321, Dec 2019.

John P Plastaras, Elise A Chong, Stephen J Schuster: Don't Get Stuck on the Shoulder: Radiation Oncologists Should Get Into the CAR With T-Cell Therapies. Int J Radiat Oncol Biol Phys 105(5): 1022-1024, Dec 2019.

Elise A. Chong , Bruce L. Levine , Stephan A. Grupp , Megan M. Davis , Don L. Siegel , Shannon L. Maude , Whitney L. Gladney , Noelle V. Frey , David L. Porter , Wei-Ting Hwang , Emeline R. Chong , Carl H. June , Stephen J. Schuster : CAR T Cell Viability Release Testing and Clinical Outcomes: Is There a Lower Limit? Blood 134(21): 1873–1875, Nov 2019.

Farhan A, Chong EA, Schuster SJ, Strelec L, Nasta SD, Landsburg D, Svoboda J.: Bexarotene in Patients With Peripheral T-cell Lymphomas: Results of a Retrospective Study. Clin Lymphoma Myeloma Leuk 19(2): 109-115, Feb 2019.

Chong EA, Svoboda J, Nasta SD, Landsburg DL, Winchell N, Napier E, Mato AR, Melenhorst JJ, Ruella M, Lacey SM, June CH, Schuster SJ.: Sequential Anti CD 19 Directed Chimeric Antigen Receptor Modified T Cell Therapy (CART19) and PD 1 Blockade with Pembrolizumab in Patients with Relapsed or Refractory B Cell Non Hodgkin Lymphomas. American Society of Hematology Annual Meeting, San Diego, CA Dec 2018 Notes: "Poster Presentation"

Chong EA, Levine BL, Grupp SA, Davis M, Siegel DL, Maude SL, Gladney WL, Frey NV, Porter DL, June CH, Schuster SJ. : CD 19 Directed CAR T Cell (CTL019) Product Viability and Clinical Outcomes in Non Hodgkin Lymphomas and B Cell Acute Lymphoblastic Leukemia. American Society of Hematology Annual Meeting, San Diego, CA Dec 2018 Notes: "Oral Presentation"

Mato AR, Dorsey C, Chatburn ET, Geoghegan J, Schuster SJ, Svoboda J, Becker PS, Chong EA, Nasta SD, Landsburg DJ, Kennard K, Luning-Prak E, Tsao PS, Hughes ME, Purdom M, Paskalis D, Sportelli P, Miskin HP, Weiss MS, Shadman M. : Phase I/II Study of Pembrolizumab in Combination with TG-1101 (ublituximab) and TGR-1202 (umbralisib) in Patients with Relapsed Refractory CLL or Richter’s Transformation of CLL. American Society of Hematology Annual Meeting, Atlanta, GA Dec 2017 Notes: "Poster Presentation"

Schuster SJ, Svoboda J, Chong EA, Nasta SD, Mato AR, Anak Ö, Brogdon JL, Pruteanu-Malinici I, Bhoj V, Landsburg D, Wasik M, Levine BL, Lacey SF, Melenhorst JJ, Porter DL, June CH.: Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas. N Engl J Med 377(26): 2545-2554, Dec 28 2017.

back to top
Last updated: 05/07/2020
The Trustees of the University of Pennsylvania